It takes guts and science: Unlock the latest research behind human milk oligosaccharides (HMOs) for human health
Discover new science behind human milk oligosaccharides in gut health and immunity to guide your next supplement development.
Harnessing the power of HMOs to deliver advanced gut care throughout life
Consumer interest in gut health has increased threefold in the last five years,1 indicating this is quickly becoming a priority for many individuals worldwide. A staggering 74% of consumers aim to eat foods that support a healthy microbiome and 57% of consumers are interested in products that enhance their digestion.2 This strong consumer pull creates an opportunity for brands to leverage emerging science to bring new and innovative gut health solutions to the dietary supplements market. Human milk oligosaccharides (HMOs) are unique, gut-strengthening nutrients, scientifically proven to support digestive health and immunity, which is closely linked to the gut. An already important nutrient in infant nutrition commonly found in human milk, advancements in science now allow the benefits of HMOs to be leveraged throughout life via dietary supplement innovation.
Driven by lifestyle disruption in an ever-changing world, consumer demand for gut health is on the rise.
Emerging clinical data demonstrates that supplementation with select HMOs can positively impact the gut microbiota.3
Our market-leading HMO portfolio and regulatory approvals help you deliver purpose-led, science-backed gut health solutions.
Interested in expanding your offering to support digestive health? Explore the benefits of HMOs in consumer health and learn how dsm-firmenich supports dietary supplement innovation with its comprehensive GlyCare® HMO portfolio.
The next generation of HMO sports nutritional products, developed in collaboration with Team dsm-firmenich PostNL, to help further strengthen gut health, even under the most challenging circumstances.
Our GlyCare® HMOs do more to help consumers stay healthy, active and resilient throughout life. dsm-firmenich is a market-leading pioneer of safe, science-backed oligosaccharides. We are the world’s leading innovator and supplier, offering the broadest portfolio of commercially available HMOs globally. Discover how our GlyCare® range provides the building blocks for nutrition solutions targeting key health areas, including gut, across all life stages.
2’FL (2’fucosyllactose) is the most abundant fucosylated HMO in human milk at ~2g/L, particularly well-known for its role in infant health and, more recently, its benefits across life. Research shows that GlyCare® 2’FL helps to balance gut microbiota by stimulating beneficial bacteria, such as bifidobacterial.4 It may also support gut barrier function5,6 and immunity7,8.
LNnT is one of the most abundant neutral core HMOs in human milk. Like GlyCare® 2’FL, GlyCare® LNnT promotes the growth of ‘good’ bacteria and therefore supports balanced gut microbiota.9,10,11 Further science shows that it may also help to develop and mature the gut, strengthen the gut barrier4 and support immune function12.
Harness the power of HMOs for gut health.
Nourish
Selectively feeds good bacteria.
Protect
Attenuates the influence of undesirable bacteria onto human cells.
Reinforce
Decreases the adhesion of undesirable bacteria to human intestinal cells.
All of our HMO products come with our quality guarantee to meet or exceed the following requirements: FS 22000 Certification, ISO 9001, SMETA four pillar
dsm-firmenich is spearheading innovation in the field of oligosaccharides with the widest range of commercially available HMOs. As a reliable end-to-end, innovative and purpose-led provider, dsm-firmenich offers a broad portfolio of science-backed products and customized solutions powered by expert services uniquely aimed at supporting your entire product life cycle, from concept to consumer. This takes more than ingredients, it takes a partner.
dsm-firmenich's new, science-backed approach to gut health supports and preserves the key pillars of a healthy gut ecosystem to deliver wide-ranging health benefits.
Clinical research has shown that HMOs may help to optimize microbiota development in infants by nourishing beneficial bacteria.
The HMO donation program was established in 2010 to expand the knowledge and support the research in HMOs. To date, over 100 projects have been supported through the donation program.
Discover new science behind human milk oligosaccharides in gut health and immunity to guide your next supplement development.
Discover the potential of synergistic synbiotics in supporting infant gut health and development, as presented by dsm-firmenich and Lallemand Health Solutions at ESPGHAN 2024.
Discover how dsm-firmenich and Indena's partnership is creating the next-generation of dietary supplement solutions with botanical extracts.
Got a notion for your next project or breakthrough innovation? Let’s put our heads together.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
Solutions to address consumers' health and lifestyle needs, giving you an edge in the market.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.